Psilocybin mushrooms, similar to LSD in their role as a serotonin 5-HT2A receptor agonist, are a recognized form of psychedelic. Current research is exploring their use in psilocybin-facilitated therapy for a range of mental health issues, such as the emotional turmoil linked with severe depression, anxiety, cluster headaches, and migraines.
For a better grasp of how shrooms assist in managing these conditions, it’s essential to delve into their metabolism within the body. This insight allows both researchers and users to understand how the active compound produces psychological and therapeutic outcomes. This article presents a basic overview of the pharmacology and pharmacokinetics of psilocybin.
[toc]
Key Takeaways:
- When psychedelic fungi are orally ingested, half of it gets absorbed and dispersed throughout the body.
- The compound in the fungi gets dephosphorylated by the enzyme alkaline phosphatase, predominantly in the liver.
- Approximately 3.4% of the compound is expelled in its unaltered form within 24 hours, with the rest primarily excreted as a stable metabolite.
What is Pharmacokinetics?
Pharmacokinetics (PK) refers to the study of how substances, such as drugs, are processed by the body once they’re introduced into the system. Although it’s a separate field, it’s connected to pharmacodynamics, which explores how a compound interacts with the body. PK investigates four main elements: absorption, distribution, metabolism, and excretion (ADME).
Grasping these processes empowers healthcare providers to prescribe the most effective medications with the least risk. It also equips them with the knowledge to customize treatments according to each patient’s distinct physiology and lifestyle.
How Does Pharmacokinetics Relate to Psilocybin?
Psilocybin and psilocin, the major active components in specific species of magic mushrooms, have attracted substantial attention from both researchers and users. Pharmacokinetics studies how the body processes these psilocybin-containing mushrooms, aiding in the understanding of their potential medicinal or recreational effects.
These compounds, commonly referred as “magic,” “psychedelic,” “medicinal,” or “sacred,” are found in certain types of fungi that are consumed, with The Mushroom species, their origin, size, growth and drying conditions, and age can significantly affect their potency levels.
Even though these mushrooms can naturally be found in the wild, scientists have managed to artificially synthesize them in laboratories. Both their natural and synthesized forms exhibit low toxicity, albeit with possible minor side effects such as nausea or vomiting.
Despite these minor physical side effects, the compounds in these mushrooms have demonstrated potential therapeutic benefits, owing to their safe profile and non-addictive nature. This has prompted researchers to investigate their applicability in psychotherapy, particularly as a treatment for anxiety and depression.
The 4 Stages of Pharmacokinetics
Psilocybin, the compound present in these mushrooms, is inactive in its original state and functions as a prodrug, converting into its active form, psilocin. This transformation is facilitated by enzymes such as alkaline phosphatase, which allows psilocin to be absorbed and distributed throughout various body tissues. However, after oral ingestion, psilocybin is not detectable in the circulatory system, feces, or urine.
Absorption
Absorption refers to the process by which the compound enters the bloodstream from the point of administration. It affects the rate and effectiveness with which the compound reaches its target, such as the plasma. The most common method of administration is oral, although inhalation has been tested but found less effective.
The compound’s release from the dosage form during oral ingestion is also part of the absorption process. Factors like delays in the throat or esophagus can affect this, potentially slowing down results or causing irritation. Once the compound gets to the stomach, its acidic environment may start to break it down before it enters the bloodstream.
Studies on animals suggest that only around 50% of orally ingested psychedelics are absorbed and distributed throughout the body.
Factors Affecting the Absorption Process
Various factors can affect the absorption process, leading to differences in the onset, intensity, and duration of effects:
- Stomach Contents: Consuming on a full stomach can slow down the process and delay the onset of effects. Faster absorption is possible on an empty stomach.
- Body Fat: Compounds can accumulate in fat tissues, potentially prolonging their effects.
- Age: Metabolic rates and body composition are subject to changes with age.
- Zero-Order Kinetics: The substance is eliminated at a constant rate, regardless of its concentration.
- First-Order Kinetics: The elimination rate is directly proportional to the drug’s concentration.
Dissemination alludes to the distribution of psilocin throughout the body once it enters the bloodstream. Due to its lipophilic properties, psilocin can cross the blood-brain barrier, allowing it to access the central nervous system.
This process is largely influenced by factors such as the product’s size, polarity, protein-binding capacity, and the individual’s physiology — including hydration status and body composition.
The goal is to achieve an effective concentration in the target area. For the product to be beneficial, it needs to reach the intended location (as determined by the volume of distribution) and remain unattached to proteins, allowing it to actively interact with its receptor.
What Factors Influence the Dissemination Process?
The process of dissemination can be impacted by several elements:
Typically, the effects start to manifest within 20-40 minutes of consumption, peaking around 80-100 minutes. The influence of magic mushrooms usually persists for 4-6 hours.
How is Dissemination to the Brain Achieved?
An initial experimental study on two species unveiled that the order of binding affinity is 5HT2A > 5HT1A > 5HT2B [23]. It also attaches to dopamine D1, 5HT1E, 5HT5A, 5HT7, 5HT6, D3, 5HT2C, and 5HT1B receptors.
It acts as a partial agonist at the 5HT2A receptor, demonstrating an efficacy around 40%. The psychedelic effects may be ascribed to its partial agonist activity at 5HT1A autoreceptors.
The mood elevation and psychotomimetic experiences might result from the noticed association between heightened dopamine levels and sensations of bliss and depersonalization. Hallucinogens operate by modifying neurochemistry and receptor activity. It enhances 5HT2A agonist activity by augmenting BDNF production in the hippocampus, which subsequently fosters neurogenesis and alleviates conditioned fear-related behaviors.
Expulsion
Expulsion is the procedure through which the
The human body eliminates substances chiefly through the kidneys, but also through the lungs, skin, or gastrointestinal tract. When it comes to the kidneys, they filter or secrete a naturally occurring psychedelic drug in the glomerulus or tubules, with some reabsorption adding complexity to the elimination process.
The main substance has a half-life of roughly 160 minutes, while psilocin’s half-life is about 50 minutes. Animal studies indicate that the majority of this is primarily excreted in the urine, accounting for roughly 65% within 8 hours. Even after consumption, traces of the substance can be detected in smaller amounts in bile and feces.
In the human body, around 3.4% of the substance is discharged in its original form within a day, while the majority is expelled as psilocin-O-glucuronide, a more stable metabolite. This stability allows the compound’s presence to be detected in urine samples for an extended time.
There are two primary methods of substance elimination:
Most psychedelic drugs adhere to the first-order kinetics method, achieving steady-state concentrations after four to five half-lives. Complete elimination also happens after four to five half-lives.
Discover Our Range of Hallucinogenic Mushrooms
The metabolic process varies among different types of mushrooms. By buying from trusted online suppliers like Magic Mushies Canada, you can prevent the accidental consumption of poisonous mushrooms. Certain types, such as Agaric mushrooms, may produce strong and unfavorable effects. Hence, it is crucial to obtain magic mushrooms from reliable dispensaries instead of risky street vendors or wild foraging.
| Feature | Enigma | Full Moon Party | Gold Member | |
| Strain Type | Psilocybe Cubensis OMNI | Psilocybe cubensis (Thai Koh Samui) | Psilocybe cubensis | |
| Potency | Exceptionally high; 3.8% tryptamine content | Moderate to high potency | High potency | |
| Visual Characteristics | Resembles a blob or | Resembles a brain or cauliflower | Follows the typical cubensis look; moderately sized | Characterized by thick white stems, caramel-colored golden caps, and visible blue bruising |
| Effects | Considered the most potent, delivering intense effects | Offers a strong mental high with a delayed onset that brings about vivid visuals | Induces potent visuals coupled with euphoria |
Online Learning Resources on Psilocybin Mushroom Usage
Grasping the pharmacokinetics of shrooms is essential for users, researchers, and healthcare professionals. It allows you to make well-informed decisions about dosage and timing, thereby reducing potential risks.
Discover your perfect psychedelic experience at Magic Mushies Canada. Whether you desire a soothing trip or a deeper exploration, our varied collection is crafted to meet your individual needs. Enjoy top-tier, safe, and quality-controlled shrooms, eliminating worries about uncertain origins or poisonous mushrooms.
Explore the best magic mushrooms Canada has to offer and heighten your psychedelic journey to unparalleled heights.
Frequently Asked Questions
Are there any known interactions between shrooms and other drugs?
Our products may interact with certain drugs, particularly those that affect serotonin levels like SSRIs (Selective Serotonin Reuptake Inhibitors). SSRIs and SNRIs (Serotonin and Norepinephrine Reuptake Inhibitors) typically decrease the effects, unlike non-serotonergic antidepressants. This reduced effect can last for up to three months after stopping the use of the antidepressant.
Do all psychedelics operate the same way as psilocybin?
No, each psychedelic substance has a distinctive structure that requires different metabolic processes to activate, and they bind to various receptors in the body. The mode of administration also affects the absorption of each psychedelic. Although the basic principles of absorption, metabolism, and distribution are the same, the specific pathways and effects vary for each substance.
Can the form of the shroom affect the pharmacokinetics?
Indeed, the form (whether fresh, powdered, or dried mushrooms) can influence the rate of absorption. For example, powdered forms may be absorbed faster than whole dried ones due to quicker dissolution.
Related Reads:
